Human herpesvirus 6 encephalitis simulating brain metastases in a patient with advanced small-cell lung cancer

Chemotherapy. 2013;59(5):385-6. doi: 10.1159/000360616. Epub 2014 May 13.

Abstract

Background: The brain is a frequent site of metastases in small-cell lung cancer. Symptoms of cerebral involvement are headache, disorientation, nausea/vomiting and seizures.

Case: A man with small-cell lung cancer developed a human herpesvirus 6 (HHV-6) meningoencephalitis with neurological symptoms that simulated brain involvement from the lung cancer. HHV-6 is a T cell lymphotropic virus which may be pathogenic in the immunocompromised host. HHV-6 remains latent after the first infection, and when the immune system is compromised it can reactivate. The treatment of HHV-6 infection is highly specific and the drugs recommended are the two antivirals, ganciclovir or foscarnet.

Conclusion: In cancer patients neurologic symptoms are usually due to brain metastases. This case shows that in a cancer patient any aspecific neurologic symptom should be carefully evaluated in order to exclude a non-oncologic cause. This statement is particularly true if the therapies for the oncological and neurological diseases are effective.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / secondary
  • Encephalitis, Viral / diagnosis*
  • Encephalitis, Viral / drug therapy
  • Encephalitis, Viral / physiopathology
  • Foscarnet / therapeutic use
  • Ganciclovir / therapeutic use
  • Herpesvirus 6, Human / isolation & purification
  • Humans
  • Immunocompromised Host
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Roseolovirus Infections / diagnosis*
  • Roseolovirus Infections / drug therapy
  • Roseolovirus Infections / physiopathology
  • Small Cell Lung Carcinoma / pathology*

Substances

  • Antiviral Agents
  • Foscarnet
  • Ganciclovir

Supplementary concepts

  • Human Herpesvirus 6 encephalitis